(ny-moh-TOO-zoo-mab) A monoclonal antibody being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Nimotuzumab binds the epidermal growth factor receptor (EGFR) and blocks cancer cells that depend on epidermal growth factor for growth. Also called Theraloc.
- Browse Related Terms: ABX-EGF, CD40-ligand, cetuximab, EMD 72000, Erbitux, Herceptin, indium In 111 CHX-A DTPA trastuzumab, matuzumab, nimotuzumab, panitumumab, R1507, Theraloc, trastuzumab, Vectibix